1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Yuan, X. Downing, A.K. Knott, V. Handford, P.A. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK EMBO J. EMJODG 0897 0261-4189 16 6659 6666 10.1093/emboj/16.22.6659 9362480 Solution structure of the transforming growth factor beta-binding protein-like module, a domain associated with matrix fibrils. 1997 10.2210/pdb1apj/pdb pdb_00001apj 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 8018.965 FIBRILLIN TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN-LIKE DOMAIN 6(TB6), RESIDUES 2054 - 2125 1 man polymer no no SAQDLRMSYCYAKFEGGKCSSPKSRNHSKQECCCALKGEGWGDPCELCPTEPDEAFRQICPYGSGIIVGPDDSA SAQDLRMSYCYAKFEGGKCSSPKSRNHSKQECCCALKGEGWGDPCELCPTEPDEAFRQICPYGSGIIVGPDDSA A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia sample TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN-LIKE DOMAIN 6(TB6), RESIDUES 2054-2125 9606 Homo sapiens 562 Escherichia coli NM554 PQE30 database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1998-01-28 1 1 2008-03-24 1 2 2011-07-13 1 3 2021-11-03 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site _struct_ref_seq_dif.details Y BNL 1997-07-22 REL 21 BRUNGER refinement X-PLOR 3.1 SER 1 n 1 SER 1 A ALA 2 n 2 ALA 2 A GLN 2054 n 3 GLN 2054 A ASP 2055 n 4 ASP 2055 A LEU 2056 n 5 LEU 2056 A ARG 2057 n 6 ARG 2057 A MET 2058 n 7 MET 2058 A SER 2059 n 8 SER 2059 A TYR 2060 n 9 TYR 2060 A CYS 2061 n 10 CYS 2061 A TYR 2062 n 11 TYR 2062 A ALA 2063 n 12 ALA 2063 A LYS 2064 n 13 LYS 2064 A PHE 2065 n 14 PHE 2065 A GLU 2066 n 15 GLU 2066 A GLY 2067 n 16 GLY 2067 A GLY 2068 n 17 GLY 2068 A LYS 2069 n 18 LYS 2069 A CYS 2070 n 19 CYS 2070 A SER 2071 n 20 SER 2071 A SER 2072 n 21 SER 2072 A PRO 2073 n 22 PRO 2073 A LYS 2074 n 23 LYS 2074 A SER 2075 n 24 SER 2075 A ARG 2076 n 25 ARG 2076 A ASN 2077 n 26 ASN 2077 A HIS 2078 n 27 HIS 2078 A SER 2079 n 28 SER 2079 A LYS 2080 n 29 LYS 2080 A GLN 2081 n 30 GLN 2081 A GLU 2082 n 31 GLU 2082 A CYS 2083 n 32 CYS 2083 A CYS 2084 n 33 CYS 2084 A CYS 2085 n 34 CYS 2085 A ALA 2086 n 35 ALA 2086 A LEU 2087 n 36 LEU 2087 A LYS 2088 n 37 LYS 2088 A GLY 2089 n 38 GLY 2089 A GLU 2090 n 39 GLU 2090 A GLY 2091 n 40 GLY 2091 A TRP 2092 n 41 TRP 2092 A GLY 2093 n 42 GLY 2093 A ASP 2094 n 43 ASP 2094 A PRO 2095 n 44 PRO 2095 A CYS 2096 n 45 CYS 2096 A GLU 2097 n 46 GLU 2097 A LEU 2098 n 47 LEU 2098 A CYS 2099 n 48 CYS 2099 A PRO 2100 n 49 PRO 2100 A THR 2101 n 50 THR 2101 A GLU 2102 n 51 GLU 2102 A PRO 2103 n 52 PRO 2103 A ASP 2104 n 53 ASP 2104 A GLU 2105 n 54 GLU 2105 A ALA 2106 n 55 ALA 2106 A PHE 2107 n 56 PHE 2107 A ARG 2108 n 57 ARG 2108 A GLN 2109 n 58 GLN 2109 A ILE 2110 n 59 ILE 2110 A CYS 2111 n 60 CYS 2111 A PRO 2112 n 61 PRO 2112 A TYR 2113 n 62 TYR 2113 A GLY 2114 n 63 GLY 2114 A SER 2115 n 64 SER 2115 A GLY 2116 n 65 GLY 2116 A ILE 2117 n 66 ILE 2117 A ILE 2118 n 67 ILE 2118 A VAL 2119 n 68 VAL 2119 A GLY 2120 n 69 GLY 2120 A PRO 2121 n 70 PRO 2121 A ASP 2122 n 71 ASP 2122 A ASP 2123 n 72 ASP 2123 A SER 2124 n 73 SER 2124 A ALA 2125 n 74 ALA 2125 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 A N SER 2059 A N SER 8 A O HIS 2078 A O HIS 27 A O GLU 2097 A O GLU 46 A N TRP 2092 A N TRP 41 A O GLY 2091 A O GLY 40 A N TYR 2062 A N TYR 11 A N ALA 2063 A N ALA 12 A O SER 2072 A O SER 21 1 A ARG 2057 0.290 SIDE CHAIN 1 A ARG 2076 0.254 SIDE CHAIN 2 A ARG 2057 0.202 SIDE CHAIN 2 A ARG 2076 0.191 SIDE CHAIN 2 A ARG 2108 0.306 SIDE CHAIN 3 A ARG 2057 0.103 SIDE CHAIN 3 A ARG 2076 0.306 SIDE CHAIN 4 A ARG 2057 0.117 SIDE CHAIN 4 A ARG 2076 0.163 SIDE CHAIN 5 A ARG 2057 0.255 SIDE CHAIN 5 A ARG 2076 0.209 SIDE CHAIN 5 A ARG 2108 0.171 SIDE CHAIN 6 A ARG 2057 0.211 SIDE CHAIN 6 A ARG 2076 0.303 SIDE CHAIN 6 A ARG 2108 0.141 SIDE CHAIN 7 A ARG 2057 0.114 SIDE CHAIN 7 A ARG 2076 0.250 SIDE CHAIN 7 A ARG 2108 0.298 SIDE CHAIN 8 A ARG 2057 0.284 SIDE CHAIN 8 A ARG 2076 0.286 SIDE CHAIN 8 A ARG 2108 0.304 SIDE CHAIN 9 A ARG 2057 0.225 SIDE CHAIN 9 A ARG 2076 0.251 SIDE CHAIN 9 A ARG 2108 0.296 SIDE CHAIN 10 A ARG 2057 0.156 SIDE CHAIN 10 A ARG 2108 0.281 SIDE CHAIN 11 A ARG 2057 0.078 SIDE CHAIN 11 A ARG 2076 0.235 SIDE CHAIN 11 A ARG 2108 0.084 SIDE CHAIN 12 A ARG 2057 0.206 SIDE CHAIN 12 A ARG 2076 0.200 SIDE CHAIN 12 A ARG 2108 0.304 SIDE CHAIN 13 A ARG 2057 0.254 SIDE CHAIN 13 A ARG 2076 0.262 SIDE CHAIN 13 A ARG 2108 0.261 SIDE CHAIN 14 A ARG 2057 0.306 SIDE CHAIN 14 A ARG 2076 0.300 SIDE CHAIN 14 A ARG 2108 0.234 SIDE CHAIN 15 A ARG 2057 0.267 SIDE CHAIN 15 A ARG 2076 0.207 SIDE CHAIN 16 A ARG 2057 0.236 SIDE CHAIN 16 A ARG 2076 0.290 SIDE CHAIN 17 A ARG 2057 0.135 SIDE CHAIN 17 A ARG 2076 0.291 SIDE CHAIN 17 A ARG 2108 0.306 SIDE CHAIN 18 A ARG 2057 0.277 SIDE CHAIN 18 A ARG 2076 0.228 SIDE CHAIN 18 A ARG 2108 0.266 SIDE CHAIN 19 A ARG 2057 0.291 SIDE CHAIN 19 A ARG 2076 0.308 SIDE CHAIN 19 A ARG 2108 0.223 SIDE CHAIN 20 A ARG 2057 0.265 SIDE CHAIN 20 A ARG 2108 0.295 SIDE CHAIN 21 A ARG 2076 0.182 SIDE CHAIN 1 A LEU 2056 27.72 47.26 1 A SER 2059 -113.14 -163.17 1 A GLU 2066 -91.20 57.24 1 A SER 2072 70.95 56.65 1 A CYS 2085 -106.64 -62.71 1 A LYS 2088 28.10 73.66 1 A CYS 2096 -28.10 125.51 1 A SER 2115 -54.92 88.44 1 A ILE 2117 51.05 -85.92 1 A VAL 2119 -36.66 116.29 1 A ASP 2122 43.92 27.58 1 A SER 2124 158.49 165.56 2 A ALA 2 53.12 -178.36 2 A LEU 2056 38.18 41.90 2 A SER 2059 -116.44 -159.24 2 A SER 2079 -41.64 153.55 2 A LYS 2088 30.45 77.60 2 A CYS 2096 -27.22 123.81 2 A PRO 2103 -92.62 31.78 2 A SER 2115 -100.60 67.23 2 A ILE 2117 -26.12 -77.87 2 A ILE 2118 167.12 66.32 2 A ASP 2122 87.29 -47.43 2 A SER 2124 59.48 97.11 3 A ALA 2 173.68 -161.08 3 A GLN 2054 -49.03 -174.82 3 A ASP 2055 -89.00 45.79 3 A LEU 2056 45.65 22.94 3 A SER 2059 -120.47 -161.25 3 A LYS 2088 31.00 70.12 3 A CYS 2096 -27.45 111.28 3 A LEU 2098 -35.39 95.29 3 A PRO 2103 -94.04 31.39 3 A ILE 2117 49.16 -86.27 3 A VAL 2119 -29.33 -37.53 3 A SER 2124 -166.36 -56.94 4 A ALA 2 65.92 139.11 4 A ASP 2055 57.37 93.75 4 A SER 2059 -107.59 -165.36 4 A SER 2075 -37.62 -35.99 4 A ARG 2076 -109.15 -169.43 4 A LYS 2088 30.08 77.14 4 A CYS 2096 -26.92 122.12 4 A LEU 2098 -37.67 110.36 4 A PRO 2103 -94.63 30.44 4 A SER 2115 -47.37 88.25 4 A ILE 2117 61.53 -86.65 4 A VAL 2119 -29.53 -44.76 4 A PRO 2121 -44.86 86.00 4 A ASP 2122 38.22 38.74 5 A ALA 2 69.17 129.19 5 A LEU 2056 32.14 41.79 5 A LYS 2088 29.08 67.83 5 A CYS 2096 -27.34 124.18 5 A LEU 2098 -31.83 116.78 5 A SER 2115 -66.82 84.35 5 A VAL 2119 -36.54 -34.86 5 A PRO 2121 -62.25 87.66 5 A ASP 2122 165.16 -27.79 5 A ASP 2123 -118.17 70.92 5 A SER 2124 -35.76 144.67 6 A LEU 2056 36.33 47.42 6 A SER 2059 -113.41 -161.34 6 A SER 2079 -32.17 149.50 6 A LYS 2088 25.96 73.32 6 A CYS 2096 -27.38 119.79 6 A LEU 2098 -31.99 131.82 6 A PRO 2103 -93.19 33.91 6 A ILE 2117 -147.64 -48.92 6 A VAL 2119 -19.06 -47.10 6 A PRO 2121 -44.49 96.02 6 A ASP 2122 85.38 -40.69 6 A ASP 2123 81.77 39.55 6 A SER 2124 169.61 165.54 7 A GLN 2054 -69.72 83.81 7 A LEU 2056 30.91 43.32 7 A SER 2072 68.93 60.41 7 A LYS 2074 -39.91 125.22 7 A CYS 2085 -125.70 -62.52 7 A LYS 2088 44.89 90.53 7 A CYS 2096 -27.26 126.67 7 A SER 2115 -84.78 44.01 7 A ILE 2117 -155.65 -40.23 7 A ILE 2118 130.12 56.25 7 A PRO 2121 -59.30 83.64 7 A ASP 2122 33.76 32.79 7 A ASP 2123 -90.18 39.03 7 A SER 2124 -95.65 30.02 8 A ALA 2 56.23 109.04 8 A ASP 2055 44.70 28.68 8 A LEU 2056 26.83 47.33 8 A GLU 2066 -79.53 -167.62 8 A SER 2072 79.49 60.32 8 A LYS 2074 -82.95 45.18 8 A SER 2075 34.02 -89.23 8 A CYS 2085 -133.78 -41.54 8 A LYS 2088 26.23 71.68 8 A CYS 2096 -27.25 126.45 8 A LEU 2098 -32.22 108.60 8 A SER 2115 -45.41 87.43 8 A VAL 2119 -32.47 -34.18 8 A PRO 2121 -48.00 83.73 8 A ASP 2123 45.70 82.28 8 A SER 2124 -33.69 108.10 9 A GLN 2054 -111.87 51.89 9 A LEU 2056 29.70 47.28 9 A SER 2059 -127.93 -160.67 9 A LYS 2074 -50.42 -168.25 9 A CYS 2085 -130.95 -36.24 9 A CYS 2096 -27.05 120.42 9 A SER 2115 -51.81 87.36 9 A ILE 2117 52.93 -86.98 9 A VAL 2119 -24.78 -84.21 9 A PRO 2121 -82.86 43.13 9 A ASP 2122 173.05 -31.26 9 A SER 2124 -87.21 -86.91 10 A LEU 2056 25.23 49.20 10 A GLU 2066 -92.96 57.53 10 A LYS 2074 -49.42 157.07 10 A ARG 2076 -85.21 -158.58 10 A LYS 2088 23.43 50.93 10 A CYS 2096 -27.61 132.83 10 A LEU 2098 -37.58 113.04 10 A PRO 2103 -94.00 30.34 10 A ILE 2117 32.42 34.23 10 A ILE 2118 27.00 54.46 10 A VAL 2119 -37.57 -27.76 10 A ASP 2123 -86.86 39.83 11 A ALA 2 58.48 -170.32 11 A GLN 2054 -76.07 -169.70 11 A LEU 2056 49.99 23.02 11 A TYR 2060 -33.68 131.27 11 A SER 2072 67.79 61.84 11 A LYS 2088 56.76 72.24 11 A CYS 2096 -27.23 122.91 11 A LEU 2098 -34.39 114.85 11 A SER 2115 -51.86 89.16 11 A ILE 2117 56.43 -85.94 11 A ILE 2118 -119.25 72.66 11 A VAL 2119 -33.88 -32.76 11 A PRO 2121 -67.35 81.47 11 A SER 2124 36.94 95.52 12 A ALA 2 51.24 -172.13 12 A ASP 2055 -41.44 92.01 12 A LEU 2056 -36.64 -27.15 12 A SER 2079 -43.29 167.83 12 A LYS 2088 31.27 84.88 12 A CYS 2096 -27.45 125.11 12 A PRO 2103 -95.16 33.55 12 A ILE 2117 -20.56 -84.20 12 A ILE 2118 174.72 42.61 12 A ASP 2122 -155.62 -42.21 13 A LEU 2056 31.01 36.17 13 A GLU 2066 -85.48 48.82 13 A LYS 2074 -53.43 -166.08 13 A SER 2079 -34.16 154.45 13 A LYS 2088 30.79 77.81 13 A CYS 2096 -27.13 120.27 13 A LEU 2098 -32.59 125.75 13 A SER 2115 -45.32 80.35 13 A ILE 2118 -94.02 -76.22 13 A ASP 2122 33.96 31.98 13 A ASP 2123 -99.49 40.44 14 A GLN 2054 -114.49 59.51 14 A LEU 2056 -95.77 39.46 14 A ARG 2057 -27.35 148.83 14 A SER 2059 -107.57 -161.03 14 A LYS 2088 59.85 97.23 14 A CYS 2096 -27.44 121.42 14 A LEU 2098 -33.23 100.33 14 A PRO 2103 -93.86 30.10 14 A SER 2115 -40.54 89.63 14 A ILE 2117 -13.39 -66.44 14 A ILE 2118 145.41 53.11 14 A ASP 2122 35.62 38.53 14 A ASP 2123 -119.36 69.64 15 A LEU 2056 36.33 44.44 15 A SER 2059 -137.74 -158.87 15 A ALA 2063 -32.81 -31.04 15 A GLU 2066 -91.54 57.54 15 A SER 2072 61.91 61.83 15 A SER 2075 -37.67 -37.70 15 A SER 2079 -31.15 143.68 15 A LYS 2088 31.31 73.36 15 A CYS 2096 -27.49 123.26 15 A LEU 2098 -55.59 108.19 15 A PRO 2103 -97.80 33.34 15 A SER 2115 -101.06 63.25 15 A ILE 2118 -91.86 -72.62 15 A PRO 2121 -38.54 93.18 15 A ASP 2122 159.34 -25.57 15 A ASP 2123 -145.39 59.43 15 A SER 2124 -178.95 -43.04 16 A ALA 2 159.05 -172.28 16 A SER 2072 82.83 59.31 16 A LYS 2074 -58.29 173.29 16 A SER 2079 -34.36 142.79 16 A LYS 2088 30.03 82.37 16 A CYS 2096 -27.92 107.88 16 A LEU 2098 -35.16 118.19 16 A PRO 2103 -91.05 30.61 16 A SER 2115 -52.86 88.17 16 A ILE 2117 -9.12 -70.67 16 A ILE 2118 152.34 60.76 16 A SER 2124 34.75 69.29 17 A ASP 2055 47.05 29.80 17 A LEU 2056 29.18 38.33 17 A SER 2072 69.30 60.14 17 A SER 2075 -39.20 -39.54 17 A ARG 2076 -129.78 -163.30 17 A LYS 2088 33.01 72.24 17 A CYS 2096 -27.01 133.94 17 A VAL 2119 -29.79 -37.01 17 A ASP 2122 85.92 -35.66 17 A SER 2124 -35.02 -75.47 18 A ALA 2 169.07 136.87 18 A ASP 2055 41.19 29.67 18 A LEU 2056 29.05 44.53 18 A SER 2059 -118.31 -159.53 18 A LYS 2088 39.57 85.67 18 A CYS 2096 -27.32 124.36 18 A LEU 2098 -35.10 116.44 18 A SER 2115 -51.92 88.17 18 A ILE 2117 26.80 -82.50 18 A ILE 2118 -111.24 75.63 18 A PRO 2121 -43.79 84.53 18 A ASP 2122 39.16 28.34 18 A ASP 2123 51.82 75.52 18 A SER 2124 -45.26 170.19 19 A ASP 2055 35.85 32.41 19 A LEU 2056 26.92 49.83 19 A SER 2059 -128.16 -162.35 19 A SER 2072 72.73 58.23 19 A LYS 2088 32.13 69.66 19 A CYS 2096 -27.06 129.64 19 A LEU 2098 -37.40 106.79 19 A SER 2115 -48.30 87.17 19 A VAL 2119 -31.35 -38.05 19 A SER 2124 -35.76 -75.17 20 A ALA 2 63.40 -179.02 20 A GLN 2054 -71.93 -151.12 20 A SER 2072 71.10 59.64 20 A SER 2079 -32.04 153.77 20 A LYS 2088 34.50 74.43 20 A CYS 2096 -27.29 121.25 20 A LEU 2098 -32.75 127.42 20 A SER 2115 -53.58 87.75 20 A ILE 2118 -156.46 75.11 20 A VAL 2119 -24.69 -67.23 20 A PRO 2121 -58.63 89.57 20 A ASP 2122 29.05 37.73 20 A ASP 2123 -102.18 73.15 21 A ASP 2055 34.31 32.00 21 A LEU 2056 -107.66 72.00 21 A ARG 2057 -28.85 134.26 21 A ALA 2063 -39.85 -28.85 21 A SER 2072 78.45 64.90 21 A SER 2079 -36.22 154.12 21 A LYS 2088 50.41 95.06 21 A CYS 2096 -27.09 128.24 21 A LEU 2098 -32.58 119.95 21 A PRO 2103 -93.50 30.54 21 A ASP 2104 -48.06 154.41 21 A ILE 2117 -26.61 -82.83 21 A ILE 2118 173.68 59.99 21 A ASP 2122 33.36 38.10 model building X-PLOR 3.1 refinement X-PLOR 3.1 phasing X-PLOR 3.1 NMR STUDY OF THE TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN-LIKE DOMAIN (TB MODULE/8-CYS DOMAIN), NMR, 21 STRUCTURES 1 Y N A LYS 2080 A LYS 29 HELX_P A CYS 2084 A CYS 33 1 H1 5 A GLU 2105 A GLU 54 HELX_P A ILE 2110 A ILE 59 1 H2 6 disulf 2.020 A CYS 2061 A SG CYS 10 1_555 A CYS 2083 A SG CYS 32 1_555 disulf 2.016 A CYS 2070 A SG CYS 19 1_555 A CYS 2096 A SG CYS 45 1_555 disulf 2.025 A CYS 2084 A SG CYS 33 1_555 A CYS 2099 A SG CYS 48 1_555 disulf 2.019 A CYS 2085 A SG CYS 34 1_555 A CYS 2111 A SG CYS 60 1_555 EXTRACELLULAR MATRIX FIBRILLIN FRAGMENT, MICROFIBRIL, TB MODULE, MARFAN SYNDROME, CONNECTIVE TISSUE, NOVEL FOLD, EXTRACELLULAR MATRIX A GLU 2102 A GLU 51 1 A PRO 2103 A PRO 52 0.10 A GLU 2102 A GLU 51 2 A PRO 2103 A PRO 52 0.06 A GLU 2102 A GLU 51 3 A PRO 2103 A PRO 52 0.25 A GLU 2102 A GLU 51 4 A PRO 2103 A PRO 52 0.13 A GLU 2102 A GLU 51 5 A PRO 2103 A PRO 52 0.14 A GLU 2102 A GLU 51 6 A PRO 2103 A PRO 52 -0.06 A GLU 2102 A GLU 51 7 A PRO 2103 A PRO 52 0.06 A GLU 2102 A GLU 51 8 A PRO 2103 A PRO 52 0.02 A GLU 2102 A GLU 51 9 A PRO 2103 A PRO 52 0.14 A GLU 2102 A GLU 51 10 A PRO 2103 A PRO 52 0.13 A GLU 2102 A GLU 51 11 A PRO 2103 A PRO 52 0.19 A GLU 2102 A GLU 51 12 A PRO 2103 A PRO 52 0.21 A GLU 2102 A GLU 51 13 A PRO 2103 A PRO 52 -0.01 A GLU 2102 A GLU 51 14 A PRO 2103 A PRO 52 -0.04 A GLU 2102 A GLU 51 15 A PRO 2103 A PRO 52 0.25 A GLU 2102 A GLU 51 16 A PRO 2103 A PRO 52 0.05 A GLU 2102 A GLU 51 17 A PRO 2103 A PRO 52 0.02 A GLU 2102 A GLU 51 18 A PRO 2103 A PRO 52 -0.14 A GLU 2102 A GLU 51 19 A PRO 2103 A PRO 52 0.12 A GLU 2102 A GLU 51 20 A PRO 2103 A PRO 52 0.14 A GLU 2102 A GLU 51 21 A PRO 2103 A PRO 52 -0.08 FBN1_HUMAN UNP 1 1 P35555 MRRGRLLEIALGFTVLLASYTSHGADANLEAGNVKETRASRAKRRGGGGHDALKGPNVCGSRYNAYCCPGWKTLPGGNQC IVPICRHSCGDGFCSRPNMCTCPSGQIAPSCGSRSIQHCNIRCMNGGSCSDDHCLCQKGYIGTHCGQPVCESGCLNGGRC VAPNRCACTYGFTGPQCERDYRTGPCFTVISNQMCQGQLSGIVCTKQLCCATVGRAWGHPCEMCPAQPHPCRRGFIPNIR TGACQDVDECQAIPGLCQGGNCINTVGSFECKCPAGHKLNEVSQKCEDIDECSTIPGICEGGECTNTVSSYFCKCPPGFY TSPDGTRCIDVRPGYCYTALTNGRCSNQLPQSITKMQCCCDAGRCWSPGVTVAPEMCPIRATEDFNKLCSVPMVIPGRPE YPPPPLGPIPPVLPVPPGFPPGPQIPVPRPPVEYLYPSREPPRVLPVNVTDYCQLVRYLCQNGRCIPTPGSYRCECNKGF QLDLRGECIDVDECEKNPCAGGECINNQGSYTCQCRAGYQSTLTRTECRDIDECLQNGRICNNGRCINTDGSFHCVCNAG FHVTRDGKNCEDMDECSIRNMCLNGMCINEDGSFKCICKPGFQLASDGRYCKDINECETPGICMNGRCVNTDGSYRCECF PGLAVGLDGRVCVDTHMRSTCYGGYKRGQCIKPLFGAVTKSECCCASTEYAFGEPCQPCPAQNSAEYQALCSSGPGMTSA GSDINECALDPDICPNGICENLRGTYKCICNSGYEVDSTGKNCVDINECVLNSLLCDNGQCRNTPGSFVCTCPKGFIYKP DLKTCEDIDECESSPCINGVCKNSPGSFICECSSESTLDPTKTICIETIKGTCWQTVIDGRCEININGATLKSQCCSSLG AAWGSPCTLCQVDPICGKGYSRIKGTQCEDIDECEVFPGVCKNGLCVNTRGSFKCQCPSGMTLDATGRICLDIRLETCFL RYEDEECTLPIAGRHRMDACCCSVGAAWGTEECEECPMRNTPEYEELCPRGPGFATKEITNGKPFFKDINECKMIPSLCT HGKCRNTIGSFKCRCDSGFALDSEERNCTDIDECRISPDLCGRGQCVNTPGDFECKCDEGYESGFMMMKNCMDIDECQRD PLLCRGGVCHNTEGSYRCECPPGHQLSPNISACIDINECELSAHLCPNGRCVNLIGKYQCACNPGYHSTPDRLFCVDIDE CSIMNGGCETFCTNSEGSYECSCQPGFALMPDQRSCTDIDECEDNPNICDGGQCTNIPGEYRCLCYDGFMASEDMKTCVD VNECDLNPNICLSGTCENTKGSFICHCDMGYSGKKGKTGCTDINECEIGAHNCGKHAVCTNTAGSFKCSCSPGWIGDGIK CTDLDECSNGTHMCSQHADCKNTMGSYRCLCKEGYTGDGFTCTDLDECSENLNLCGNGQCLNAPGGYRCECDMGFVPSAD GKACEDIDECSLPNICVFGTCHNLPGLFRCECEIGYELDRSGGNCTDVNECLDPTTCISGNCVNTPGSYICDCPPDFELN PTRVGCVDTRSGNCYLDIRPRGDNGDTACSNEIGVGVSKASCCCSLGKAWGTPCEMCPAVNTSEYKILCPGGEGFRPNPI TVILEDIDECQELPGLCQGGKCINTFGSFQCRCPTGYYLNEDTRVCDDVNECETPGICGPGTCYNTVGNYTCICPPDYMQ VNGGNNCMDMRRSLCYRNYYADNQTCDGELLFNMTKKMCCCSYNIGRAWNKPCEQCPIPSTDEFATLCGSQRPGFVIDIY TGLPVDIDECREIPGVCENGVCINMVGSFRCECPVGFFYNDKLLVCEDIDECQNGPVCQRNAECINTAGSYRCDCKPGYR FTSTGQCNDRNECQEIPNICSHGQCIDTVGSFYCLCHTGFKTNDDQTMCLDINECERDACGNGTCRNTIGSFNCRCNHGF ILSHNNDCIDVDECASGNGNLCRNGQCINTVGSFQCQCNEGYEVAPDGRTCVDINECLLEPRKCAPGTCQNLDGSYRCIC PPGYSLQNEKCEDIDECVEEPEICALGTCSNTEGSFKCLCPEGFSLSSSGRRCQDLRMSYCYAKFEGGKCSSPKSRNHSK QECCCALKGEGWGDPCELCPTEPDEAFRQICPYGSGIIVGPDDSAVDMDECKEPDVCKHGQCINTDGSYRCECPFGYTLA GNECVDTDECSVGNPCGNGTCKNVIGGFECTCEEGFEPGPMMTCEDINECAQNPLLCAFRCVNTYGSYECKCPVGYVLRE DRRMCKDEDECEEGKHDCTEKQMECKNLIGTYMCICGPGYQRRPDGEGCVDENECQTKPGICENGRCLNTRGSYTCECND GFTASPNQDECLDNREGYCFTEVLQNMCQIGSSNRNPVTKSECCCDGGRGWGPHCEICPFQGTVAFKKLCPHGRGFMTNG ADIDECKVIHDVCRNGECVNDRGSYHCICKTGYTPDITGTSCVDLNECNQAPKPCNFICKNTEGSYQCSCPKGYILQEDG RSCKDLDECATKQHNCQFLCVNTIGGFTCKCPPGFTQHHTSCIDNNECTSDINLCGSKGICQNTPGSFTCECQRGFSLDQ TGSSCEDVDECEGNHRCQHGCQNIIGGYRCSCPQGYLQHYQWNQCVDENECLSAHICGGASCHNTLGSYKCMCPAGFQYE QFSGGCQDINECGSAQAPCSYGCSNTEGGYLCGCPPGYFRIGQGHCVSGMGMGRGNPEPPVSGEMDDNSLSPEACYECKI NGYPKRGRKRRSTNETDASNIEDQSETEANVSLASWDVEKTAIFAFNISHVSNKVRILELLPALTTLTNHNRYLIESGNE DGFFKINQKEGISYLHFTKKKPVAGTYSLQISSTPLYKKKELNQLEDKYDKDYLSGELGDNLKMKIQVLLH 2049 2125 1APJ 1 2125 P35555 A 1 1 74 1 ARG engineered mutation SER 1 1APJ A P35555 UNP 2052 1 1 CYS engineered mutation ALA 2 1APJ A P35555 UNP 2053 2 2 4 anti-parallel anti-parallel anti-parallel anti-parallel A MET 2058 A MET 7 A SER 2059 A SER 8 A HIS 2078 A HIS 27 A SER 2079 A SER 28 A GLU 2097 A GLU 46 A LEU 2098 A LEU 47 A GLY 2091 A GLY 40 A TRP 2092 A TRP 41 A CYS 2061 A CYS 10 A PHE 2065 A PHE 14 A CYS 2070 A CYS 19 A PRO 2073 A PRO 22 1 P 1